Position in INCY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$258,551,825
+$72,613,626 QoQ
Shares Held
2,280,803
+15.5% QoQ
Ownership
1.14%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#17
of 854 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 75%
Shared 22%
None 3%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DIMENSIONAL FUND ADVISORS LP holds $6,105,781,867 across 230 Biotechnology names. INCY ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,168,956 | $580,655,511 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
1,713,592 | $412,924,262 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
559,687 | $348,987,230 | |
| 4 | INCY |
Incyte Corp
This page
|
2,280,803 | $258,551,825 | |
| 5 | EXEL |
Exelixis, Inc.
|
4,426,620 | $240,852,392 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
4,075,714 | $233,212,353 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
5,230,417 | $185,104,455 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
476,038 | $176,929,041 |
All Filings in INCY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,551,825 | 2,280,803 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $185,938,199 | 1,975,544 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $176,619,523 | 1,788,190 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $135,367,699 | 1,596,129 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $94,520,211 | 1,387,962 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $80,723,744 | 1,333,175 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $91,552,628 | 1,325,505 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $93,372,065 | 1,412,588 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $71,608,524 | 1,181,269 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $54,155,907 | 950,604 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $59,689,804 | 950,626 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $51,313,970 | 888,246 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $52,631,376 | 845,484 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $54,389,676 | 752,590 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $56,850,253 | 707,797 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $45,861,711 | 688,201 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $46,545,221 | 612,679 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $47,336,067 | 596,022 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $40,579,483 | 552,854 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $36,361,785 | 528,668 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $38,303,631 | 455,291 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $33,040,318 | 406,550 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $35,757,999 | 411,106 | Shares | Defined | 2021-03-08 | |
| 2020-09-30 | $37,012,545 | 412,442 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $40,928,726 | 393,659 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $29,657,564 | 404,992 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||